Tezampanel
CAS No. 150131-78-5
Tezampanel( LY 293558 | NGX 424 )
Catalog No. M12089 CAS No. 150131-78-5
Tezampanel (LY 293558, NGX 424) is a competitive antagonist of the AMPA and kainate receptors with selectivity for the GluR5 subtype of the kainate receptor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameTezampanel
-
NoteResearch use only, not for human use.
-
Brief DescriptionTezampanel (LY 293558, NGX 424) is a competitive antagonist of the AMPA and kainate receptors with selectivity for the GluR5 subtype of the kainate receptor.
-
DescriptionTezampanel (LY 293558, NGX 424) is a competitive antagonist of the AMPA and kainate receptors with selectivity for the GluR5 subtype of the kainate receptor; has neuroprotective and anticonvulsant properties, also has anxiolytic effects in animal studies.
-
In Vitro——
-
In Vivo——
-
SynonymsLY 293558 | NGX 424
-
PathwayMembrane Transporter/Ion Channel
-
TargetiGluR
-
RecptoriGluR
-
Research AreaNeurological Disease
-
IndicationMigraine
Chemical Information
-
CAS Number150131-78-5
-
Formula Weight279.344
-
Molecular FormulaC13H21N5O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC1CC2CNC(CC2CC1CCC3=NNN=N3)C(=O)O
-
Chemical Name(3S,4aR,6R,8aR)-6-[2-(1H-tetrazol-5-yl)ethyl]decahydroisoquinoline-3-carboxylic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Ornstein PL, et al. J Med Chem. 1993 Jul 9;36(14):2046-8.
2. LeBlanc MH, et al. Stroke. 1995 Oct;26(10):1908-14; discussion 1914-5.
3. Benvenga MJ, et al. J Pharmacol Exp Ther. 1995 Oct;275(1):164-70.
molnova catalog
related products
-
Zonampanel
Zonampanel (YM 872) is a selective, potent and highly water-soluble, competitive AMPA receptor (AMPAR) antagonist with Ki of 96 nM.
-
AMPA receptor antago...
AMPA receptor antagonist-3 is an AMPA receptor antagonist.
-
Rislenemdaz hydrochl...
Rislenemdaz (MK 0657;CERC 301) is a potent, orally bioavailable, brain‐penetrant, NR2B-selective NMDA receptor (GluN2B) antagonist with Ki and IC 50 of 8.1 nM and 3.6 nM respectively.
Cart
sales@molnova.com